Gastric Cancer Clinical Trials in Arnhem
2 recruitingArnhem, Netherlands
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Gastroesophageal Junction AdenocarcinomaHER2-positive Gastric Cancer
AstraZeneca840 enrolled284 locationsNCT06764875
Recruiting
Phase 2Phase 3
[18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer
Gastric CancerLocally Advanced Gastric AdenocarcinomaPET/CT+1 more
Leiden University Medical Center250 enrolled10 locationsNCT07018661